and Centrum multivitamins, making it the second-largest consumer health company in the world. Haleon is not issuing any new shares as a result of the flotation, with existing GSK shareholders ...

Midas has unearthed significant directors' deals of recent weeks - purchases that would seem to suggest those at the top ...

Sensodyne’s latest campaign highlights Sensitivity as a chronic oral health condition and educates consumers: Our Bureau, Mumbai Friday, May 23, 2025, 17:30 Hrs [IST] Sensodyne, ...

Long-term results from the Women’s Health Initiative have revealed associations between cancers and hormone therapy, supplements, diet, BMI, metabolic syndrome, and NSAIDs.

GSK plc GSK announced that it has signed an agreement with Massachusetts-based biopharmaceutical company Boston Pharmaceuticals to acquire the latter’s lead pipeline drug, efimosfermin alfa ...

Alyson Hannigan, Ask2BSure spokesperson, actress, and mom, stars in an Ask2BSure campaign video to raise awareness about meningitis and vaccination amongst parents of teens and young adults.

GSK has stopped development of anti-TIGIT antibody belrestotug. The Big Pharma and its partner iTeos Therapeutics took the action after an assessment of the effect on progression-free survival ...

GSK agreed to buy an experimental medicine from a Cambridge biotech for as much as $2 billion to shore up its drug pipeline and muscle into the promising field of liver therapies. The treatment ...

GSK has already moved on from its decision to drop a cancer asset on Tuesday by snagging a late-stage liver disease candidate for a hefty $1.2 billion upfront. That drug in question is ...

British pharmaceutical company GSK (NYSE:GSK) to acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, for as much as $2 billion in cash. Under the agreement, GSK will pay $1.2 billion ...

May 14 (Reuters) - GSK (GSK.L), opens new tab will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm Boston Pharmaceuticals ...